Profil

Fontaine Alexis

GIGA Cancer - Cellular and Molecular Epigenetics

Département GxABT > TERRA Research Centre

Microbial technologies

See author's contact details
Main Referenced Co-authors
Hamaïdia, Malik  (5)
Jamakhani, Majeed  (5)
Willems, Luc  (5)
Brossel, Hélène  (4)
Duysinx, Bernard  (4)
Main Referenced Keywords
chemotherapy (2); eosinophils (2); mesothelioma (2); Cancer Research (1); chemoresistance (1);
Main Referenced Disciplines
Oncology (5)
Immunology & infectious disease (1)

Publications (total 5)

The most downloaded
32 downloads
Hoyos, C., Fontaine, A., Brossel, H., Willems, M., Jamakhani, M., Vandermeers, F., Safari, R., HEINEN, V., LOUIS, R., DUYSINX, B., Scherpereel, A., Wasielewski, E., Mascaux, C., Hamaïdia, M.* , & Willems, L.*. (14 December 2021). Contribution of lysine deacetylases to the therapy of malignant pleural mesothelioma [Poster presentation]. Giga Cancer Day, Liège, Belgium. https://hdl.handle.net/2268/289479

The most cited

4 citations (Scopus®)

Brossel, H., Fontaine, A., Hoyos, C., Jamakhani, M., Willems, M., Hamaïdia, M., & Willems, L. (2021). Activation of DNA Damage Tolerance Pathways May Improve Immunotherapy of Mesothelioma. Cancers, 13, 3211. doi:10.3390/cancers13133211 https://hdl.handle.net/2268/267149

Willems, M., Scherpereel, A., Wasielewski, E., Raskin, J., Brossel, H., Fontaine, A., Grégoire, M., Halkin, L., Jamakhani, M., Heinen, V., Louis, R., Duysinx, B., Hamaïdia, M.* , & Willems, L.*. (2023). Excess of blood eosinophils prior to therapy correlates with worse prognosis in mesothelioma. Frontiers in Immunology, 14, 1148798. doi:10.3389/fimmu.2023.1148798
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Hoyos, C.* , Fontaine, A.* , Jacques, J.-R., Heinen, V., Louis, R., Duysinx, B., Scherpereel, A., Wasielewski, E., Jamakhani, M.* , Hamaïdia, M.* , & Willems, L.*. (2022). HDAC Inhibition with Valproate Improves Direct Cytotoxicity of Monocytes against Mesothelioma Tumor Cells. Cancers, 14 (9), 2164. doi:10.3390/cancers14092164
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Hoyos, C., Fontaine, A., Brossel, H., Willems, M., Jamakhani, M., Vandermeers, F., Safari, R., HEINEN, V., LOUIS, R., DUYSINX, B., Scherpereel, A., Wasielewski, E., Mascaux, C., Hamaïdia, M.* , & Willems, L.*. (14 December 2021). Contribution of lysine deacetylases to the therapy of malignant pleural mesothelioma [Poster presentation]. Giga Cancer Day, Liège, Belgium.
* These authors have contributed equally to this work.

Willems, M., Jamakhani, M., Scherpereel, A., Wasielewski, E., Brossel, H., Fontaine, A., Hoyos, C., Grégoire, M., Louis, R., Duysinx, B., Hamaïdia, M.* , & Willems, L.*. (14 December 2021). Eosinophils inhibit malignant pleural mesothelioma response to chemotherapy [Poster presentation]. GIGA-Cancer Day, Liège, Belgium.
* These authors have contributed equally to this work.

Brossel, H., Fontaine, A., Hoyos, C., Jamakhani, M., Willems, M., Hamaïdia, M., & Willems, L. (2021). Activation of DNA Damage Tolerance Pathways May Improve Immunotherapy of Mesothelioma. Cancers, 13, 3211. doi:10.3390/cancers13133211
Peer Reviewed verified by ORBi

Contact ORBi